Description Comparison of two FDA cases from the 1960s and the early 2000s.
Book Elhauge, Einer (2010) The Fragmentation of U.S. Health Care: Causes and Solutions.
Article
Daemmrich, A.;
(2007)
Pharmaceutical Regulation in the United States and Europe
(/isis/citation/CBB001221028/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/isis/citation/CBB001221032/)
Chapter
Hess, Volker;
(2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century
(/isis/citation/CBB001221034/)
Thesis
Schwartz, Jason Lee;
(2012)
External Factors: Advisory Committees, Regulation, and American Public Health, 1962--1999
(/isis/citation/CBB001567388/)
Chapter
Simon, Jonathan;
(2008)
French Serum Regulation in 1895: The Necessary Minimum or the Maximum Possible?
(/isis/citation/CBB001221038/)
Article
Abraham, John;
Davis, Courtney;
(2006)
Testing Times: The Emergence of the Practolol Disaster and Its Challenge to British Drug Regulation in the Modern Period
(/isis/citation/CBB000770617/)
Article
Sihn, Kyu-hwan;
(2013)
The Institutionalization of Pharmaceutical Administration after the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law (Yaksabeop) in 1953
(/isis/citation/CBB001214039/)
Article
Daemmrich, Arthur;
Bowden, Mary Ellen;
(2005)
A Rising Drug Industry: Pharmaceuticals since 1870
(/isis/citation/CBB001221029/)
Book
Horace A. Bartilow;
(2019)
Drug War Pathologies: Embedded Corporatism and U.S. Drug Enforcement in the Americas
(/isis/citation/CBB525075418/)
Article
Gabriel, Joseph M.;
(2011)
Restricting the Sale of “Deadly Poisons”: Pharmacists, Drug Regulation, and Narratives of Suffering in the Gilded Age
(/isis/citation/CBB001220743/)
Article
Horwitz, Allan V.;
(2011)
Naming the Problem That Has No Name: Creating Targets for Standardized Drugs
(/isis/citation/CBB001221532/)
Article
Pieters, Toine;
Majerus, Benoît;
(2011)
The Introduction of Chlorpromazine in Belgium and the Netherlands (1951--1968); Tango between Old and New Treatment Features
(/isis/citation/CBB001221534/)
Article
Herzberg, David;
(2011)
Blockbusters and Controlled Substances: Miltown, Quaalude, and Consumer Demand for Drugs in Postwar America
(/isis/citation/CBB001221531/)
Article
Balz, Viola;
Hoheisel, Matthias;
(2011)
East-Side Story: The Standardisation of Psychotropic Drugs at the Charité Psychiatric Clinic, 1955--1970
(/isis/citation/CBB001221535/)
Book
Mikkael A. Sekeres;
(2022)
Drugs and the FDA: Safety, Efficacy, and the Public's Trust
(/isis/citation/CBB614307145/)
Article
Judy Z Segal;
(August 2018)
Sex, drugs, and rhetoric: The case of flibanserin for ‘female sexual dysfunction’
(/isis/citation/CBB311917478/)
Article
Tobbell, Dominique A.;
(2008)
Allied against Reform: Pharmaceutical Industry--Academic Physician Relations in the United States, 1945--1970
(/isis/citation/CBB000930716/)
Article
Kuo, Wen-Hua;
(2009)
The Voice on the Bridge: Taiwan's Regulatory Engagement with Global Pharmaceuticals
(/isis/citation/CBB001021062/)
Book
Daemmrich, Arthur A.;
(2004)
Pharmacopolitics: Drug Regulation in the United States and Germany
(/isis/citation/CBB000501505/)
Article
Healy, David;
Mangin, Derelie;
Applbaum, Kalman;
(2014)
The Shipwreck of the Singular
(/isis/citation/CBB001421185/)
Be the first to comment!